Teladoc Health, Inc.
- Open
- 9.78
- Day high
- 9.89
- Day low
- 9.38
- Prev close
- 9.72
- Volume
- 3.7M
- Mkt cap
- $1.7B
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 1.3
- P/S
- 0.7
- Yield
- —
- Per share
- —
- ▼Insiders net selling -$270K over the last 3 months (0 open-market buys, 6 sales)
- 🏛Institutions mixed (13F)
Teladoc Health, Inc. (TDOC) is a Healthcare company listed on NYSE. The stock is up 23% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 6 sales (SEC Form 4).
Teladoc Health, Inc. (TDOC) financials & analyst ratings
Fundamentals (TTM)
Analyst consensus · 2 analysts
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
TDOC earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 29, 2026 | $-0.34 | $-0.36 | -5.5% | $614M | +0.5% |
| Feb 25, 2026 | $-0.19 | $-0.14 | +24.9% | $642M | +2.4% |
| Oct 29, 2025 | $-0.26 | $-0.21 | +19.2% | $626M | -1.4% |
| Apr 30, 2025 | $-0.33 | $-0.19 | +42.4% | $629M | +1.6% |
| Feb 26, 2025 | $-0.21 | $-0.28 | -33.3% | $640M | +0.2% |
| Oct 30, 2024 | $-0.29 | $-0.19 | +34.5% | $641M | +0.0% |
| Jul 31, 2024 | $-0.36 | $-0.28 | +22.2% | $642M | -1.1% |
| Apr 25, 2024 | $-0.47 | $-0.49 | -4.3% | $646M | +1.4% |
| Feb 20, 2024 | $-0.22 | $-0.17 | +22.7% | $661M | -1.6% |
| Jul 25, 2023 | $-0.44 | $-0.40 | +9.1% | $652M | +0.5% |
| Feb 22, 2023 | $-0.27 | $-0.23 | +14.8% | $638M | +0.7% |
| Oct 26, 2022 | $-0.59 | $-0.45 | +23.7% | $611M | +0.4% |
TDOC insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Catapano Joseph Ronaldofficer: Chief Accounting Officer | Option | 2,083 | — |
| Jul 6, 2026 | Bliss Kellyofficer: President, U.S. Group Health | Sell | 2,500 | $9.50 |
| Jul 6, 2026 | Catapano Joseph Ronaldofficer: Chief Accounting Officer | Sell | 653 | $9.10 |
| Jul 1, 2026 | Bliss Kellyofficer: President, U.S. Group Health | Sell | 2,500 | $9.00 |
| Jun 30, 2026 | Bliss Kellyofficer: President, U.S. Group Health | Sell | 2,500 | $8.50 |
| Jun 12, 2026 | DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER | Option | 3,642 | — |
| Jun 12, 2026 | DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 18,074 | $6.94 |
| Jun 12, 2026 | DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER | Option | 39,160 | — |
| Jun 4, 2026 | Rodrigues Fernando M.officer: President of BetterHelp | Sell | 9,572 | $7.40 |
| May 21, 2026 | Jacobson Catherinedirector | Option | 28,986 | — |
| May 21, 2026 | Jacobson Catherinedirector | Grant | 30,441 | — |
| May 21, 2026 | SNOW DAVID B JRdirector | Option | 28,986 | — |
| May 21, 2026 | SHEDLARZ DAVID Ldirector | Grant | 30,441 | — |
| May 21, 2026 | SHEDLARZ DAVID Ldirector | Option | 29,986 | — |
| May 21, 2026 | Fenwick Sandra Ldirector | Grant | 30,441 | — |
Source: TDOC SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
See the full TDOC insider & 13F page →Teladoc Health, Inc. company profile
Overview
Teladoc Health, Inc. (NYSE:TDOC) is a leading virtual healthcare company founded in 2002 and headquartered in Purchase, New York. Originally incorporated as Teladoc, Inc., the company changed its name to Teladoc Health in August 2018 to reflect its expanded healthcare services portfolio. The company went public in June 2015 and has since grown through strategic acquisitions to become one of the largest telemedicine providers globally. Today, Teladoc Health operates two primary business segments: an Integrated Care division serving healthcare organizations and employers, and BetterHelp, a direct-to-consumer mental health platform acquired through the company's purchase of Livongo and subsequent strategic moves.
Business
Teladoc Health operates in the virtual healthcare services industry, providing remote medical consultations and digital health solutions through technology platforms. The company's core offering centers around telemedicine - the practice of delivering healthcare services remotely using telecommunications technology, allowing patients to consult with healthcare providers via video calls, phone calls, or messaging without visiting a physical medical facility. The company operates through two distinct business segments. The Integrated Care segment generates approximately 60% of total revenue and provides virtual healthcare services to employers, health plans, hospitals, and health systems. This segment includes general medical consultations for non-urgent conditions, chronic disease management programs for conditions like diabetes and hypertension, specialty care services, and mental health solutions delivered through a business-to-business model. The Integrated Care division serves over 100 million members in the United States and operates internationally. The BetterHelp segment accounts for roughly 40% of revenue and operates as a direct-to-consumer mental health platform. BetterHelp connects individuals directly with licensed therapists and counselors through an online platform, offering text-based therapy, video sessions, and phone consultations. Users pay subscription fees to access mental health services without going through traditional healthcare systems or insurance providers. This segment has expanded internationally and serves hundreds of thousands of active users globally. Both segments leverage proprietary technology platforms that facilitate secure communication between patients and healthcare providers, maintain electronic health records, and integrate with existing healthcare infrastructure. The virtual care model addresses healthcare access challenges by reducing geographical barriers, providing 24/7 availability for many services, and offering more convenient alternatives to traditional in-person medical visits.
Revenue model
Teladoc Health generates revenue through multiple business models across its two primary segments. The Integrated Care segment primarily operates on a subscription-based model, charging healthcare organizations, employers, and health plans either per-member-per-month (PMPM) fees or visit-based fees for access to virtual healthcare services. Corporate clients pay to provide telemedicine benefits to their employees, while health plans integrate Teladoc's services into their coverage offerings. The company also generates revenue from chronic care management programs, where it receives ongoing fees for managing patients with conditions like diabetes, hypertension, and heart disease. The BetterHelp segment operates on a direct-pay subscription model, where individual consumers pay weekly or monthly fees ranging from approximately $60-90 per week for unlimited access to licensed therapists. This segment relies heavily on digital marketing and advertising to acquire customers, with significant spending on social media platforms, search engines, and other online channels. Revenue is directly tied to the number of active paying subscribers and their retention rates. Several factors influence the company's margins and profitability. Customer acquisition costs significantly impact BetterHelp's margins, as the segment must continuously invest in marketing to attract new subscribers in a competitive mental health market. Rising advertising costs on platforms like Facebook and Google can compress margins. Provider supply and costs affect both segments, as Teladoc must maintain adequate networks of physicians, therapists, and specialists while managing compensation costs. Technology infrastructure investments are essential for platform reliability and feature development but require ongoing capital allocation. Regulatory changes in telemedicine reimbursement policies, licensing requirements across states, and healthcare privacy regulations can impact operational costs and market access. Competition from traditional healthcare providers expanding virtual offerings, as well as new telemedicine startups, creates pricing pressure and increases customer acquisition costs across both business segments.
Competitive moat
Teladoc Health's competitive moat is moderate but faces increasing challenges from multiple directions. The company's primary advantages stem from its scale and network effects in the Integrated Care segment, where it has built relationships with over 100 million covered members and maintains one of the largest networks of healthcare providers for virtual consultations. This scale allows Teladoc to spread technology development costs across a large user base and provides bargaining power with both healthcare providers and corporate clients. The company has also developed proprietary technology platforms and clinical protocols that integrate with existing healthcare systems, creating some switching costs for enterprise clients. However, the moat is not particularly deep or defensible long-term. In the Integrated Care segment, traditional healthcare systems, major health insurers, and technology companies like Amazon and Microsoft are increasingly developing competing virtual care offerings. The core telemedicine technology is not proprietary, and many healthcare providers are building in-house capabilities rather than outsourcing to third-party platforms. Additionally, regulatory changes that expanded telemedicine access during COVID-19 have made it easier for new competitors to enter the market. The BetterHelp segment faces even more significant competitive threats, operating in a crowded direct-to-consumer mental health market with low barriers to entry. Competitors include other online therapy platforms like Talkspace and Cerebral, traditional therapy practices expanding online, and new venture-backed startups. The segment's reliance on digital marketing creates vulnerability to platform algorithm changes and rising advertising costs. Unlike traditional healthcare relationships, BetterHelp's customer relationships are less sticky, with users able to easily switch between platforms. The company's international expansion efforts face competition from local telemedicine providers who better understand regional healthcare systems and regulations. Overall, while Teladoc Health benefits from first-mover advantages and scale, the competitive landscape is intensifying across both segments, limiting the durability of its current market position.
Risks & safety
Teladoc Health presents moderate financial risk with some concerning liquidity and profitability metrics, though the company maintains adequate cash reserves. **Cash and Debt Position:** - Cash and short-term investments: $1.19 billion (Q1 2025) - Strong current ratio: 1.68, indicating good short-term liquidity - Debt-to-equity ratio: 1.11, representing moderate leverage - Positive free cash flow: $13.2 million (Q1 2025), though volatile historically **Profitability Concerns:** - Consistent net losses: -$93 million (Q1 2025), -$48 million (Q4 2024) - Negative EBITDA in recent quarters: -$121 million (Q1 2025) - Return on equity: -6.5% (Q1 2025) - Operating cash flow positive but inconsistent: $16 million (Q1 2025) **Valuation Metrics:** - Trading below book value: P/B ratio of 0.97 - Negative P/E ratio due to losses - EV/EBITDA not meaningful due to negative EBITDA **Other Considerations:** - Revenue stability with $629 million quarterly revenue - High cash burn relative to profitability in growth investments - Exposure to customer acquisition cost inflation in BetterHelp segment
Recent development
Over the past few years, Teladoc Health has undergone significant strategic transformation under new leadership. In 2024, the company experienced a leadership transition with long-time CEO Jason Gorevic stepping down after 15 years, followed by the appointment of Chuck Divita as the new CEO. Under Divita's leadership, the company has focused on streamlining operations, consolidating business units, and improving execution across both segments. The company has made several strategic acquisitions to expand its capabilities and market reach. Most notably, Teladoc acquired UpLift, a virtual mental health provider, to expand insurance coverage options for BetterHelp and improve conversion rates by offering benefits-covered services. The company also acquired Catapult Health to strengthen its preventative care offerings in the Integrated Care segment. These acquisitions represent efforts to create synergies between the two business segments and leverage existing customer relationships. BetterHelp segment transformation has been a major focus, with the company introducing new pricing models including weekly subscription options to make services more accessible and improve conversion rates. The segment has also expanded internationally, with international revenue now representing 20% of BetterHelp's total revenue. Management has been exploring insurance coverage integration to reduce the direct-pay burden on consumers and potentially improve customer retention. In the Integrated Care segment, Teladoc has launched next-generation solutions including an advanced cardiometabolic health program and expanded chronic care management services. The company has also been transitioning some contracts from per-member-per-month arrangements to visit-based fee structures, focusing on demonstrating value through improved clinical outcomes and return on investment metrics. The company has implemented significant cost reduction initiatives, identifying over $85 million in annual operating expense savings and reducing technology and general administrative costs. These efforts reflect a shift toward prioritizing profitability and operational efficiency alongside growth initiatives.
TDOC company profile · for informational purposes only — not investment advice.
Track TDOC with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free